The Wong termination
Sirtex Medical (ASX: SRX) is one of the stocks I've been following with a great deal of interest following another glaring executive selldown, and the ensuing insider trading probe.
Then there was also the debacle surrounding the double digit growth guidance, and the anonymous "tip-off".
The market has gotten there in the end after yesterday's study reports announcement led to another 28.3 per cent crash in the share price all the way down to $10.75 at the close.
You wouldn't like to call the bottom on a chart like this, but the market finally seems to be discounting news with a bit more healthy scepticism.